Holen Sie sich die Stockscreener-App
3.1302
3.39%
-0.1098
Schlusskurs vom Vortag:
$3.24
Offen:
$3.16
24-Stunden-Volumen:
3,849
Relative Volume:
0.05
Marktkapitalisierung:
$27.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.08M
KGV:
-2.662
EPS:
-1.1759
Netto-Cashflow:
$-2.58M
1W Leistung:
+28.29%
1M Leistung:
+2.63%
6M Leistung:
-47.87%
1J Leistung:
+160.85%
1-Tages-Spanne:
$2.96
$3.28
1-Wochen-Bereich:
$2.36
$3.28
52-Wochen-Spanne:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Firmenname
Lixte Biotechnology Holdings Inc
Sektor
Branche
Telefon
310 203 2902
Adresse
433 PLAZA REAL, BOCA RATON
Compare LIXT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.15 | 28.20M | 0 | -4.08M | -2.58M | -1.1759 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.30 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.20 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.47 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.53 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.27 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Lixte Amends Share Exchange, Clarifies Liora Ownership Structure - TipRanks
Lixte Biotechnology Enters Amended Share Exchange to Consolidate Liora Ownership With Orbit Capital - TradingView
LIXTE Biotechnology Holdings (LIXT) Adds Innovative LiGHT Therapy to Pipeline - Yahoo Finance
LIXTE Biotechnology (LIXT) Advances Lead Compound in Tumor Immunogenicity Research - NewMediaWire
LIXTE Biotechnology (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Research - TradingView
Powell Max Limited Successfully Repositions for Its Next Phase of Growth - The Manila Times
Aug Sectors: Whats the profit margin of Lixte Biotechnology Holdings IncWeekly Profit Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Trade Report: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantWeekly Gains Summary & Technical Entry and Exit Alerts - baoquankhu1.vn
Volatility Watch: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantWeekly Stock Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Why Lixte Biotechnology Holdings Inc. stock attracts high net worth investorsMarket Risk Analysis & Safe Entry Point Alerts - Naître et grandir
Wall Street Recap: Why is Lixte Biotechnology Holdings Inc Equity Warrant stock going downDollar Strength & Risk Controlled Daily Plans - baoquankhu1.vn
MACD Signal: How does Lixte Biotechnology Holdings Inc Equity Warrant perform in inflationary periodsTrade Analysis Report & Low Risk Growth Stock Ideas - baoquankhu1.vn
LIXTW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - Digital Journal
LIXTE Biotechnology (NASDAQ: LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - Digital Journal
Downgrade Watch: Will Lixte Biotechnology Holdings Inc stock go up in YEARJuly 2025 Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Should I Buy LIXT? LIXT 2026 AnalysisIntellectia AI™ - Intellectia AI
LIXTWLixte Biotechnology Hldgs Inc Latest Stock News & Market Updates - Stock Titan
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - USA Today
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - USA Today
Should I invest in Lixte Biotechnology Holdings Inc. before earningsJuly 2025 Chart Watch & Expert Approved Trade Ideas - mfd.ru
Is Lixte Biotechnology Holdings Inc. stock a value trap2025 Stock Rankings & Accurate Entry and Exit Point Alerts - mfd.ru
Why Lixte Biotechnology Holdings Inc. stock could rally in 2025July 2025 WrapUp & Precise Swing Trade Alerts - mfd.ru
What is the next catalyst for Lixte Biotechnology Holdings Inc. Equity WarrantWeekly Loss Report & Verified Trade Idea Suggestions - mfd.ru
Will Lixte Biotechnology Holdings Inc. stock go up in YEARJuly 2025 Summary & Community Verified Trade Signals - mfd.ru
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary By Investing.com - Investing.com India
LIXTE Biotechnology (LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - NewMediaWire
Lixte Elevates Liora Leadership to Advance Proton Therapy - TipRanks
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary - Investing.com
Lixte Biotechnology appoints Sidney Braun as CEO, Liora - TipRanks
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary - GlobeNewswire
LIXTE Biotechnology Appoints Sidney Braun as CEO of Its Liora Technologies Europe Ltd. Subsidiary - 富途牛牛
Growth Review: Is Cognyte Software Ltd stock a smart retirement pickMarket Risk Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
How does Lixte Biotechnology Holdings Inc. Equity Warrant perform in inflationary periodsJuly 2025 Setups & Free Daily Entry Point Trade Alerts - mfd.ru
Why is Lixte Biotechnology Holdings Inc. stock going down2025 Pullback Review & Fast Entry Momentum Alerts - mfd.ru
LIXTE Biotechnology (LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - NewMediaWire
LIXTE Biotechnology (NASDAQ: LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - Digital Journal
Can Lixte Biotechnology Holdings Inc. Equity Warrant be recession proofTrade Ideas & Short-Term High Return Strategies - mfd.ru
How is Lixte Biotechnology Holdings Inc. managing supply chain issuesWeekly Trade Recap & Capital Protection Trading Alerts - mfd.ru
How Lixte Biotechnology Holdings Inc. Equity Warrant stock trades during market volatilityJuly 2025 Levels & Daily Entry Point Trade Alerts - mfd.ru
How Lixte Biotechnology Holdings Inc. Equity Warrant stock compares to growth peersWeekly Profit Report & AI Driven Stock Price Forecasts - mfd.ru
LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - NewMediaWire
LIXTE Biotechnology (LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Yahoo Finance
LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Digital Journal
Earnings Miss: Will Lixte Biotechnology Holdings Inc Equity Warrant stock benefit from M AMarket Activity Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):